Literature DB >> 11198023

Invasive aspergillosis outbreak on a hematology-oncology ward.

D R Burwen1, B A Lasker, N Rao, E Durry, A A Padhye, W R Jarvis.   

Abstract

An outbreak of invasive aspergillosis occurred in a community hospital in temporal association with construction activity. Epidemiological investigation showed that patients who are at highest risk comprise a small group and are readily identifiable. Clinicians should strive to protect these patients, following guidelines published by the Centers for Disease Control and Prevention.

Entities:  

Mesh:

Year:  2001        PMID: 11198023     DOI: 10.1086/501826

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  Survival of some medically important fungi on hospital fabrics and plastics.

Authors:  A N Neely; M M Orloff
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.

Authors:  George Dranitsaris; Haytham Khoury
Journal:  Support Care Cancer       Date:  2010-10-23       Impact factor: 3.603

Review 3.  Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management.

Authors:  Shivaprakash M Rudramurthy; Raees A Paul; Arunaloke Chakrabarti; Johan W Mouton; Jacques F Meis
Journal:  J Fungi (Basel)       Date:  2019-07-01

4.  [Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-04       Impact factor: 1.513

Review 5.  Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings.

Authors:  G S Davis; N Sevdalis; L N Drumright
Journal:  J Hosp Infect       Date:  2014-02-26       Impact factor: 3.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.